Israel maintains a robust and active regulatory framework governing stem cell therapies, grounded in a combination of pharmaceutical, clinical trial, and genetic intervention legislation rather than a single dedicated advanced-therapy statute. The Ministry of Health (MOH) is the primary regulatory authority, operating through the Pharmacists Ordinance of 1981 and accompanying Regulations of 1986 as the principal drug registration framework Stem cell therapies occupy a dual regulatory space: est...
Subscriber brief
Read the full Stem Cell Legality in Israel
The complete assessment, the 1–5 verdict scored against our published scale, and every cited source are reserved for subscribers.
- The full Detailed Analysis and Medical Tourism Implications
- The scored 1–5 verdict and its evidence, set against the published scale
- All cited sources, set as a hanging-indent bibliography
- Factor-by-factor comparison across 19 destinations
$29.00
one-time · or subscribe for full access
Already a member? Sign in